https://vegfinhibitors.com/202....4/10/09/man-dentistr
The individual population was split into two treatment teams 24 customers which received CCRT with a 5-Fu-based routine were allocated to the PF group, and 22 patients who received CCRT with a taxane-based regimen were allotted to the DP group. The median overall survival (OS), median progression-free success (PFS), total reaction price, and treatment-related toxicity were examined. For clients within the PF team, the median OS time was 27.8 ± 9.1 months, therefore the median PFS time was 12.5 ± 2.7 mo
Like
Comment
Share
